中成药企业业绩影响因素研究——基于柯布–道格拉斯函数

Research on the Factors Influencing the Performance of Chinese Patent Medicine Enterprises—Based on Cobb Douglas Function

新冠疫情席卷全球,各国医药企业的研发创新能力受到关注,但我国中成药企业存在研发投入比例低、创新能力不足的现象。本文选取19家中成药板块企业,利用柯布–道格拉斯函数对其2011~2019的企业业绩的贡献因素进行分析,发现企业研发投入边际产出高,但对企业营业收入贡献占比少的现象,说明了我国中成药企业存在研发投入严重不足的问题。进一步,以问题为导向,本文进行了原因分析并提出了相应建议。

COVID-19 has swept the world, and the R&D capability of pharmaceutical companies in various countries has been concerned. However, there is a low proportion of R&D investment and insuffi-cient innovation capability in Chinese proprietary medicine enterprises. In this paper, 19 Chinese patent medicine enterprises are selected to analyze their contribution factors of enterprise per-formance from 2011 to 2019 by using Cobb Douglas function. It is found that the marginal output of enterprise R&D investment is high, but the contribution to enterprise operating income is small, which indicates that Chinese patent medicine enterprises have serious shortage of R&D investment. Further, this paper analyzes the causes and puts forward corresponding suggestions.